BIOLOGÍA MOLECULAR Y CELULAR EN HEMOPATÍAS
Masaryk University
Brno, República ChecaPublicacións en colaboración con investigadores/as de Masaryk University (2)
2018
-
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia - Update on methodological approaches and results interpretation
Leukemia, Vol. 32, Núm. 5, pp. 1070-1080
2013
-
Randomized phase II study of bortezomib, thalidomide, and dexamethasone with or without cyclophosphamide as induction therapy in previously untreated multiple myeloma
Journal of Clinical Oncology, Vol. 31, Núm. 2, pp. 247-255